EcoDrugPlus

Carbonic Anhydrase Iv Gene 2

Ensembl ID : ENSXETG00000034545
Gene Symbol: CA4.2
6 Enzyme and pathways 5 View Cross-references
329 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase Ix

Ensembl ID : ENSXETG00000046031
Gene Symbol: CA9
2 Enzyme and pathways 5 View Cross-references
280 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase Vb, Mitochondrial

Ensembl ID : ENSXETG00000016594
Gene Symbol: CA5B
2 Enzyme and pathways 5 View Cross-references
231 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase Vii

Ensembl ID : ENSXETG00000017420
Gene Symbol: CA7
2 Enzyme and pathways 5 View Cross-references
218 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase Xii

Ensembl ID : ENSXETG00000009722
Gene Symbol: CA12
2 Enzyme and pathways 5 View Cross-references
214 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase Xiii

Ensembl ID : ENSXETG00000026010
Gene Symbol: CA13
2 Enzyme and pathways 5 View Cross-references
288 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Casein Kinase 1 Epsilon

Ensembl ID : ENSXETG00000006357
Gene Symbol: CSNK1E
20 Enzyme and pathways 5 View Cross-references
269 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Caspase 9

Ensembl ID : ENSXETG00000046355
Gene Symbol: CASP9
14 Enzyme and pathways 5 View Cross-references
202 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Catechol O-Methyltransferase A

Ensembl ID : ENSXETG00000005683
Gene Symbol: LOC100498399
4 View Cross-references
210 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Cathepsin C

Ensembl ID : ENSXETG00000011748
Gene Symbol: CTSC
14 Enzyme and pathways 5 View Cross-references
237 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Cathepsin K

Ensembl ID : ENSXETG00000035558
Gene Symbol: LOC448216
12 Enzyme and pathways 5 View Cross-references
139 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Cathepsin S

Ensembl ID : ENSXETG00000008914
Gene Symbol: CTSS
5 View Cross-references
268 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).